ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,473.23
      0.00%
      US Tech 100
      19,414.40
      0.06%
      Dow Jones
      38,778.10
      0.00%
      Brent Oil
      83.905
      0.01%
      Bitcoin
      64,992.63
      -2.25%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BeiGene Ltd (BGNE)

      7. BeiGene Ltd (BGNE) News

      BGNE

      BeiGene (BGNE)

      BeiGene Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BGNE
      DateTimeSourceHeadlineSymbolCompany
      06/15/202412:05PMBusiness WireBeiGene présentera à l’EHA2024 de nouvelles données sur l’étude SEQUOIA évaluant la bithérapie BRUKINSA® plus vénétoclax dans le traitement de première intention de patients atteints de LLC/PLL à haut risqueNASDAQ:BGNEBeiGene Ltd
      06/15/20249:42AMBusiness WireEHA2024: BeiGene präsentiert neue Daten der SEQUOIA-Studie zu BRUKINSA® plus Venetoclax für die Erstlinienbehandlung von Hochrisiko-CLL/SLLNASDAQ:BGNEBeiGene Ltd
      06/14/20246:00AMBusiness WireBeiGene to Present New Data from SEQUOIA Study Evaluating BRUKINSA® plus Venetoclax in High-Risk First-Line CLL/SLL at EHA2024NASDAQ:BGNEBeiGene Ltd
      06/13/20247:41PMBusiness WireBeiGene and NewBridge Pharmaceuticals FZ LLC Mutually Agree to Conclude BRUKINSA® (Zanubrutinib) Partnership in the Middle East and Africa (MENA) RegionNASDAQ:BGNEBeiGene Ltd
      06/07/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20245:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20245:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/07/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BGNEBeiGene Ltd
      06/05/20245:23PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BGNEBeiGene Ltd
      06/05/20244:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BGNEBeiGene Ltd
      06/04/20246:01AMBusiness WireBeiGene to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:BGNEBeiGene Ltd
      05/28/20248:00AMGlobeNewswire Inc.BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human StudyNASDAQ:BGNEBeiGene Ltd
      05/24/20246:00AMBusiness WireBRUKINSA® Data at ASCO Underscore Differentiated Clinical Profile for Treatment of CLL and SLLNASDAQ:BGNEBeiGene Ltd
      05/15/20246:10PMBusiness WireEHA2024: BeiGene präsentiert neues Hämatologie-Portfolio und Pipeline-DatenNASDAQ:BGNEBeiGene Ltd
      05/15/20245:50PMBusiness WireBeiGene présente de nouvelles données de portefeuille et de pipeline d'hématologie à l'EHA2024NASDAQ:BGNEBeiGene Ltd
      05/14/20244:01PMBusiness WireBeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024NASDAQ:BGNEBeiGene Ltd
      05/09/20243:03PMBusiness WireBeiGene meldet Finanzergebnisse für das erste Quartal 2024 und aktuelle GeschäftsentwicklungenNASDAQ:BGNEBeiGene Ltd
      05/09/20249:38AMBusiness Wireベイジーン、2024年第1四半期決算および事業に関する最新情報を発表NASDAQ:BGNEBeiGene Ltd
      05/08/20249:02PMBusiness WireBeiGene公布2024年第一季財務業績和最新業務情況NASDAQ:BGNEBeiGene Ltd
      05/08/20247:03PMBusiness WireBeiGene présente ses résultats financiers du premier trimestre 2024 et ses dernières nouvelles commercialesNASDAQ:BGNEBeiGene Ltd
      05/08/20246:00AMBusiness WireBeiGene Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:BGNEBeiGene Ltd
      04/26/202410:34AMBusiness WireBeiGene Demonstrates Global Progress in 2023 Responsible Business & Sustainability ReportNASDAQ:BGNEBeiGene Ltd
      04/25/20247:11AMBusiness WireGlobaler Onkologie-Innovator BeiGene präsentiert auf der ASCO-Jahrestagung 2024 neue Daten aus dem gesamten Portfolio für Hämatologie und solide TumoreNASDAQ:BGNEBeiGene Ltd
       Showing the most relevant articles for your search:NASDAQ:BGNE